Table 3.
Overall number of TCC generated throughout this study
Donors | n1 | Monospecific |
n2 | Cross-reactive |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Viral Ag |
Myelin Ag |
Viral Ag |
Myelin Ag |
|||||||
229E | OC43 | MBP | PLP | 229E | OC43 | MBP | PLP | |||
80 | 34 | 19 | 12 | 4 | 2 | 2 | 2 | |||
MS | 32 | 114 | 31 | 6 | 6 | 4 |
From the blood of 32 donors (n1), we generated 145 long-term primary TCC selected with either viral or myelin Ag and 10 HCoV-myelin cross-reactive TCC were produced from the blood of 6 out of these 32 MS patients (n2).